 Jeniann Yi
Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 8 | 2023 | 295 | 2.860 |
Why?
| | Endovascular Procedures | 9 | 2024 | 301 | 2.750 |
Why?
| | Blood Vessel Prosthesis Implantation | 5 | 2024 | 197 | 2.380 |
Why?
| | Operating Rooms | 3 | 2025 | 117 | 2.250 |
Why?
| | Electronic Health Records | 4 | 2025 | 979 | 1.630 |
Why?
| | Aortic Aneurysm, Thoracic | 2 | 2023 | 127 | 1.410 |
Why?
| | Workflow | 3 | 2025 | 157 | 1.230 |
Why?
| | Kidney Failure, Chronic | 2 | 2023 | 546 | 1.030 |
Why?
| | Carotid Stenosis | 2 | 2024 | 84 | 1.020 |
Why?
| | Aortic Aneurysm, Abdominal | 2 | 2024 | 132 | 1.000 |
Why?
| | Meaningful Use | 1 | 2024 | 13 | 0.920 |
Why?
| | Peripheral Vascular Diseases | 2 | 2022 | 102 | 0.910 |
Why?
| | Incisional Hernia | 1 | 2024 | 3 | 0.900 |
Why?
| | Efficiency, Organizational | 2 | 2025 | 134 | 0.900 |
Why?
| | Sexism | 2 | 2023 | 58 | 0.900 |
Why?
| | Thrombosis | 3 | 2023 | 349 | 0.890 |
Why?
| | Pandemics | 4 | 2022 | 1500 | 0.840 |
Why?
| | Racism | 2 | 2023 | 128 | 0.800 |
Why?
| | Referral and Consultation | 2 | 2025 | 735 | 0.790 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 92 | 0.780 |
Why?
| | Congresses as Topic | 1 | 2023 | 216 | 0.770 |
Why?
| | Spinal Cord Ischemia | 1 | 2022 | 56 | 0.750 |
Why?
| | Surgeons | 3 | 2023 | 264 | 0.750 |
Why?
| | Salaries and Fringe Benefits | 1 | 2021 | 56 | 0.720 |
Why?
| | Cost Savings | 1 | 2021 | 78 | 0.720 |
Why?
| | Renal Dialysis | 2 | 2023 | 423 | 0.690 |
Why?
| | Personnel Selection | 1 | 2021 | 70 | 0.680 |
Why?
| | Physicians, Women | 1 | 2021 | 72 | 0.680 |
Why?
| | Medical Informatics | 1 | 2021 | 99 | 0.680 |
Why?
| | Stents | 5 | 2024 | 504 | 0.660 |
Why?
| | Treatment Outcome | 14 | 2024 | 10241 | 0.650 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 262 | 0.640 |
Why?
| | Administrative Claims, Healthcare | 1 | 2018 | 26 | 0.600 |
Why?
| | Hospital Charges | 1 | 2018 | 42 | 0.600 |
Why?
| | Stroke | 3 | 2024 | 1072 | 0.590 |
Why?
| | Peripheral Arterial Disease | 2 | 2022 | 458 | 0.580 |
Why?
| | Reimbursement Mechanisms | 1 | 2018 | 84 | 0.570 |
Why?
| | Quality Improvement | 3 | 2022 | 1112 | 0.560 |
Why?
| | Thoracic Outlet Syndrome | 1 | 2016 | 15 | 0.540 |
Why?
| | Osteotomy | 2 | 2018 | 102 | 0.530 |
Why?
| | Ribs | 1 | 2016 | 34 | 0.530 |
Why?
| | Research Design | 1 | 2022 | 1045 | 0.510 |
Why?
| | Incidental Findings | 1 | 2016 | 80 | 0.510 |
Why?
| | Vascular Malformations | 1 | 2016 | 51 | 0.510 |
Why?
| | Health Care Costs | 1 | 2018 | 367 | 0.480 |
Why?
| | Lymph | 1 | 2015 | 32 | 0.480 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 85 | 0.460 |
Why?
| | Humans | 35 | 2025 | 129847 | 0.460 |
Why?
| | Time Factors | 6 | 2025 | 6550 | 0.430 |
Why?
| | Risk Factors | 8 | 2024 | 9801 | 0.420 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 165 | 0.420 |
Why?
| | Retrospective Studies | 9 | 2024 | 14553 | 0.380 |
Why?
| | Adenocarcinoma | 2 | 2020 | 893 | 0.350 |
Why?
| | United States | 7 | 2024 | 13913 | 0.300 |
Why?
| | Risk Assessment | 4 | 2024 | 3269 | 0.280 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 482 | 0.270 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2511 | 0.270 |
Why?
| | Sex Factors | 2 | 2023 | 1973 | 0.260 |
Why?
| | Female | 14 | 2025 | 68829 | 0.260 |
Why?
| | Postoperative Hemorrhage | 2 | 2016 | 88 | 0.230 |
Why?
| | Colorectal Neoplasms | 1 | 2012 | 748 | 0.230 |
Why?
| | Male | 10 | 2025 | 63759 | 0.230 |
Why?
| | Lithotripsy | 1 | 2024 | 43 | 0.220 |
Why?
| | Databases, Factual | 3 | 2018 | 1269 | 0.210 |
Why?
| | Mammography | 1 | 2024 | 146 | 0.210 |
Why?
| | Vascular Patency | 1 | 2023 | 102 | 0.210 |
Why?
| | Graft Occlusion, Vascular | 1 | 2023 | 41 | 0.200 |
Why?
| | Median Arcuate Ligament Syndrome | 1 | 2022 | 1 | 0.200 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 234 | 0.200 |
Why?
| | Enoxaparin | 1 | 2023 | 59 | 0.200 |
Why?
| | Iliac Aneurysm | 1 | 2022 | 19 | 0.200 |
Why?
| | Vascular Calcification | 1 | 2024 | 107 | 0.200 |
Why?
| | Middle Aged | 7 | 2025 | 31177 | 0.190 |
Why?
| | Patients | 1 | 2023 | 169 | 0.190 |
Why?
| | Aged, 80 and over | 3 | 2024 | 7066 | 0.190 |
Why?
| | Surgical Procedures, Operative | 1 | 2024 | 244 | 0.190 |
Why?
| | Arteries | 1 | 2023 | 266 | 0.190 |
Why?
| | Dyslipidemias | 1 | 2023 | 177 | 0.190 |
Why?
| | Root Cause Analysis | 1 | 2021 | 8 | 0.190 |
Why?
| | Human Rights | 1 | 2021 | 18 | 0.180 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 287 | 0.180 |
Why?
| | Specialties, Surgical | 1 | 2022 | 74 | 0.180 |
Why?
| | Cultural Diversity | 1 | 2021 | 63 | 0.170 |
Why?
| | Burns, Electric | 1 | 2020 | 26 | 0.170 |
Why?
| | Embolization, Therapeutic | 1 | 2022 | 207 | 0.170 |
Why?
| | Health Plan Implementation | 1 | 2021 | 137 | 0.170 |
Why?
| | Iatrogenic Disease | 1 | 2020 | 60 | 0.170 |
Why?
| | Morbidity | 1 | 2021 | 302 | 0.160 |
Why?
| | Societies, Medical | 1 | 2023 | 759 | 0.160 |
Why?
| | General Surgery | 1 | 2021 | 152 | 0.160 |
Why?
| | Atherosclerosis | 1 | 2023 | 402 | 0.160 |
Why?
| | Foot | 1 | 2020 | 93 | 0.160 |
Why?
| | Infection Control | 1 | 2020 | 143 | 0.150 |
Why?
| | Tendons | 1 | 2020 | 106 | 0.150 |
Why?
| | Ischemia | 1 | 2022 | 405 | 0.150 |
Why?
| | Intermittent Claudication | 1 | 2020 | 118 | 0.150 |
Why?
| | Catheterization, Central Venous | 1 | 2020 | 104 | 0.150 |
Why?
| | Aspirin | 1 | 2022 | 380 | 0.150 |
Why?
| | Hyoid Bone | 1 | 2018 | 2 | 0.150 |
Why?
| | Current Procedural Terminology | 1 | 2018 | 12 | 0.150 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 16 | 0.150 |
Why?
| | Nerve Compression Syndromes | 1 | 2018 | 23 | 0.150 |
Why?
| | Femoral Vein | 1 | 2018 | 32 | 0.150 |
Why?
| | Intracranial Embolism | 1 | 2018 | 31 | 0.150 |
Why?
| | Academic Medical Centers | 1 | 2021 | 483 | 0.150 |
Why?
| | Carotid Artery Injuries | 1 | 2018 | 41 | 0.150 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 263 | 0.150 |
Why?
| | Hematoma | 1 | 2018 | 53 | 0.150 |
Why?
| | Urban Health Services | 1 | 2018 | 61 | 0.150 |
Why?
| | Colonic Neoplasms | 1 | 2020 | 241 | 0.150 |
Why?
| | Carotid Artery Diseases | 1 | 2018 | 64 | 0.150 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 443 | 0.150 |
Why?
| | Global Health | 1 | 2021 | 329 | 0.150 |
Why?
| | Laparoscopy | 1 | 2022 | 447 | 0.150 |
Why?
| | Vena Cava, Inferior | 1 | 2018 | 68 | 0.140 |
Why?
| | Patient Reported Outcome Measures | 1 | 2021 | 374 | 0.140 |
Why?
| | Muscle Weakness | 1 | 2018 | 85 | 0.140 |
Why?
| | Vena Cava Filters | 1 | 2018 | 60 | 0.140 |
Why?
| | Vascular System Injuries | 1 | 2018 | 73 | 0.140 |
Why?
| | Running | 1 | 2020 | 224 | 0.140 |
Why?
| | Colorado | 2 | 2018 | 4410 | 0.140 |
Why?
| | Communication | 1 | 2023 | 847 | 0.140 |
Why?
| | Rural Health Services | 1 | 2018 | 112 | 0.140 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 250 | 0.140 |
Why?
| | Anticoagulants | 1 | 2022 | 637 | 0.140 |
Why?
| | Patient Readmission | 1 | 2023 | 668 | 0.140 |
Why?
| | Program Evaluation | 1 | 2021 | 878 | 0.130 |
Why?
| | Venous Thrombosis | 1 | 2018 | 176 | 0.130 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 627 | 0.130 |
Why?
| | Aged | 4 | 2024 | 22107 | 0.130 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 96 | 0.130 |
Why?
| | Comorbidity | 1 | 2021 | 1551 | 0.130 |
Why?
| | Alarmins | 1 | 2015 | 24 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 569 | 0.120 |
Why?
| | Liver Neoplasms | 1 | 2020 | 636 | 0.120 |
Why?
| | Mesentery | 1 | 2015 | 47 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.120 |
Why?
| | Bacterial Translocation | 1 | 2015 | 40 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 336 | 0.120 |
Why?
| | Electrical Equipment and Supplies | 1 | 2015 | 8 | 0.120 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1003 | 0.120 |
Why?
| | Equipment Failure | 1 | 2015 | 106 | 0.110 |
Why?
| | Lower Extremity | 1 | 2018 | 407 | 0.110 |
Why?
| | Hypertension | 1 | 2023 | 1242 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2021 | 900 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2015 | 129 | 0.110 |
Why?
| | Adult | 5 | 2025 | 35634 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2021 | 1514 | 0.110 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 247 | 0.100 |
Why?
| | Telemedicine | 1 | 2022 | 792 | 0.100 |
Why?
| | Liver | 1 | 2020 | 1839 | 0.100 |
Why?
| | Internship and Residency | 1 | 2021 | 1058 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2008 | 0.090 |
Why?
| | Burns | 1 | 2015 | 292 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2022 | 2481 | 0.090 |
Why?
| | Incidence | 1 | 2016 | 2646 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 1 | 2015 | 2403 | 0.080 |
Why?
| | Quality of Life | 1 | 2021 | 2695 | 0.080 |
Why?
| | Treatment Failure | 2 | 2022 | 339 | 0.080 |
Why?
| | Computed Tomography Angiography | 2 | 2018 | 115 | 0.070 |
Why?
| | Patient Portals | 1 | 2024 | 42 | 0.050 |
Why?
| | Patient Navigation | 1 | 2024 | 78 | 0.050 |
Why?
| | Celiac Artery | 1 | 2022 | 10 | 0.050 |
Why?
| | Ligaments | 1 | 2022 | 54 | 0.050 |
Why?
| | Heparin | 1 | 2023 | 254 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2023 | 239 | 0.050 |
Why?
| | Abdominal Pain | 1 | 2022 | 143 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2022 | 374 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 870 | 0.040 |
Why?
| | Patient Participation | 1 | 2024 | 414 | 0.040 |
Why?
| | Arginase | 1 | 2020 | 32 | 0.040 |
Why?
| | Tenotomy | 1 | 2020 | 14 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2020 | 253 | 0.040 |
Why?
| | Aorta | 1 | 2022 | 408 | 0.040 |
Why?
| | Tendon Transfer | 1 | 2020 | 24 | 0.040 |
Why?
| | Macrophage Activation | 1 | 2020 | 189 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2020 | 96 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2021 | 298 | 0.040 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2018 | 43 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 274 | 0.040 |
Why?
| | Retroperitoneal Space | 1 | 2018 | 16 | 0.040 |
Why?
| | Phlebography | 1 | 2018 | 37 | 0.040 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2018 | 38 | 0.040 |
Why?
| | Physical Endurance | 1 | 2020 | 264 | 0.040 |
Why?
| | Head Movements | 1 | 2018 | 21 | 0.040 |
Why?
| | Cerebral Angiography | 1 | 2018 | 108 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2020 | 558 | 0.040 |
Why?
| | Patient Positioning | 1 | 2018 | 54 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 98 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2020 | 528 | 0.040 |
Why?
| | Cryopreservation | 1 | 2018 | 94 | 0.040 |
Why?
| | Animals | 2 | 2020 | 35409 | 0.040 |
Why?
| | Blood Vessel Prosthesis | 1 | 2018 | 123 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 252 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2021 | 639 | 0.030 |
Why?
| | Device Removal | 1 | 2018 | 136 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 355 | 0.030 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 443 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 766 | 0.030 |
Why?
| | Qualitative Research | 1 | 2023 | 1235 | 0.030 |
Why?
| | Reoperation | 1 | 2018 | 542 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2739 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 645 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1013 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2015 | 205 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1106 | 0.030 |
Why?
| | Fires | 1 | 2015 | 87 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2020 | 3185 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1284 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2628 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4077 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5468 | 0.020 |
Why?
| | Infant | 1 | 2023 | 9018 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5085 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 4935 | 0.020 |
Why?
| | Mice | 1 | 2020 | 16983 | 0.010 |
Why?
| | Child | 1 | 2023 | 20962 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 20451 | 0.010 |
Why?
|
|
Yi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|